These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Immunohistochemical study of endothelin-1 (ET-1) in human acute renal allograft rejection.
    Author: Wagrowska-Danilewicz M, Danilewicz M.
    Journal: Pol J Pathol; 2003; 54(2):95-100. PubMed ID: 14575417.
    Abstract:
    Immunoperoxidase staining was carried out using monoclonal antibody against endothelin-1 on renal allograft biopsy specimens from thirty one patients with acute renal transplant rejection: Banff 97 score IA (n = 11), score IB (n = 10) and score IIA (n = 10). As a control 10 biopsy specimens of the kidneys removed because of trauma were used. Endothelin-1 immunostaining was investigated in the renal interstitial vasculature and tubular epithelium. In the normal kidney the immunoreactivity of endothelin-1 was demonstrated in vascular endothelial cells and tubular epithelial cells. The intensity of endothelin-1 staining in endothelial cells in renal allograft biopsies from patients with Banff score IA and IB was similar to controls. In biopsies with Banff score IIA a marked decrease in endothelin-1 immunostaining of endothelial cells was seen. Moreover, renal tubular epithelium from patients with acute allograft rejection with Banff score IB and IIA had elevated endothelin-1 immunoreactivity as compared with controls. The results showed altered endothelin-1 immunostaining in renal biopsy specimens in patients with acute transplant rejection. In acute tubulointerstitial rejection Banff IB and acute vascular rejection Banff IIA up-regulation of endothelin-1 on tubular epithelial cells was present, meanwhile in acute vascular rejection diminished immunoreactivity of endothelin-1 on endothelial cells was noted. In conclusion, our study suggests that endothelin-1 play an important role in renal tissue injury in acute tubulointerstitial and vascular allograft rejection.
    [Abstract] [Full Text] [Related] [New Search]